ABUS
Arbutus Biopharma Corp · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +14.3% ·
share flow +8.5% ·
net new positions +12.5%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | +3 | 78.82M | $378.29M | +13 | −10 |
| Q1 2026 | 75 | -5 | 80.64M | $362.88M | +5 | −10 |
| Q4 2025 | 79 | -1 | 77.73M | $373.87M | — | −1 |
| Q3 2025 | 16 | 0 | 63.04M | $286.21M | +1 | −1 |
| Q2 2025 | 13 | +1 | 34.03M | $105.14M | +1 | — |
| Q1 2025 | 9 | 0 | 10.62M | $37.08M | — | — |
| Q4 2024 | 9 | 0 | 11.43M | $37.37M | — | — |
| Q3 2024 | 8 | +1 | 7.82M | $30.10M | +1 | — |
| Q2 2024 | 7 | — | 7.20M | $22.26M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 3.45M | +4.1% | $13.28M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 3.45M | +4.1% | $13.28M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Adage Capital Partners ✦ | 2.90M | -3.3% | $11.17M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 607.74K | +319.5% | $2.34M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 496.82K | +4.6% | $1.91M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 496.82K | +4.6% | $1.91M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Millennium Management ✦ | 250.96K | +20.1% | $966,196 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 47.80K | +7.4% | $185,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 33.72K | New | $129,815 | 0.0% | New | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 33.72K | New | $129,815 | 0.0% | New | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 33.72K | New | $129,815 | 0.0% | New | 1 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 29.73K | +99.7% | $114,445 | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| AQR Capital Management | $129,815 | 0.0% |
| AQR Capital Management | $129,815 | 0.0% |
| AQR Capital Management | $129,815 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 166 holders, 138.84M shares, $623.91M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.